Cancer Research

Thursday, February 16, 2017 - 2:31pm

Take it from George Grace: if you’ve smoked your entire life, you listen closely to news about innovative cancer treatments. Grace listened, even before a spot on his lung led to a diagnosis of early-stage non-small cell lung cancer.

Saturday, February 18, 2017 - 10:26am

The National Cancer Institute (NCI) established an initiative recently that I expect to benefit patients at Roswell Park Cancer Institute (RPCI) and around the country for years to come.

In January 2017, the agency, a member institution of the National Institutes of Health, launched the NCI Formulary to expand access to both approved drugs and investigational agents — that is, drugs still in development — that have shown promise as possible cancer therapies.

Thursday, December 29, 2016 - 12:31pm
In 2006, Shinya Yamanaka, a Japanese stem cell researcher, made a groundbreaking discovery that would win him the Nobel Prize. Yamanaka discovered a new way to turn adult, dividing cells into pluripotent stem cells.
Thursday, September 8, 2016 - 3:19pm

The report released yesterday by the Cancer Moonshot Blue Ribbon Panel, a group convened by Vice President Biden last winter, highlighted some big ideas and high-impact opportunities in oncology.

Monday, August 15, 2016 - 4:53pm

In 1951, Edwin A. Mirand, PhD, DSc became a permanent employee of Roswell Park Cancer Institute. What would have been impossible to know at the time was just how permanent a fixture he would truly become.

Friday, June 17, 2016 - 2:03pm
Danielle Twum is making it her mission to educate the public about the cutting-edge research taking place at Roswell Park, and how these breakthroughs change the way we treat cancer. The third-year pre-doctoral candidate, studying immunology in Dr. Scott Abrams’ lab, spearheaded her efforts last fall with a compelling presentation at TEDxBuffalo, an independent, local version of TED Talks.
Friday, May 13, 2016 - 11:38am
In addition to treating melanoma and sarcoma patients at Roswell Park, Joseph Skitzki, MD, FACS, spent the last few years developing a high-powered, first-of-its-kind microscope for use in the operating room. In February 2016, following a short study of the microscope’s functionality, Dr. Skitzki's research team revealed its stunning findings.
Monday, April 25, 2016 - 3:42pm
People with Down syndrome have an increased risk of developing very specific types of childhood leukemia, but Eugene Yu, PhD, has an additional reason to focus on the genetic mysteries of Down syndrome.
Monday, March 28, 2016 - 4:42pm

Roswell Park Cancer Institute made national headlines last April in securing an agreement to bring Cuba’s encouraging lung cancer vaccine, CIMAvax, to the United States for clinical testing. Nearly one year later, Cuba is back in the news and CIMAvax is receiving renewed attention. One of the most frequently asked questions about this vaccine is, “When will it be available for lung cancer patients in the U.S.?”

Tuesday, December 22, 2015 - 11:13am

Something very big is happening in the field of clinical trials (also called clinical research studies). It’s moving fast, and it will have far-reaching effects on the future of cancer research and treatment.